Non-adherence to Highly Active Antiretroviral Treatment: Review

Nzale Nzali Ntumbanzondo Arnold; Nzale Nzali Kadiombo Tshilela Anastasie; Longo-Mbenza Benjamin; Nge Okwe Augustin; Kisoka Lusunsi Christian

doi:doi:10.11648/j.ijidt.20220702.11

Non-adherence to Highly Active Antiretroviral Treatment: Review

Nzale Nzali Ntumbanzondo Arnold, Nzale Nzali Kadiombo Tshilela Anastasie, Longo-Mbenza Benjamin, Nge Okwe Augustin, Kisoka Lusunsi Christian

Published in International Journal of Infectious Diseases and Therapy (Volume 7, Issue 2)

Received: 16 March 2022 Accepted: 1 April 2022 Published: 9 April 2022

Views: Downloads:

Download PDF

Share This Article

Twitter
Linked In
Facebook

Abstract

Background and aims: This review aimed to describe factors associated with HAART non-adherence and did focus on the HIV/AIDS situation and antiretroviral therapy. Methods: The strategy of this review adopted a critical approach to reduce the bias of published or non-published information. Only evidence-based information was used from PubMed, Embase, Medline, and Google scholar. However, relevant grey information from monography/technical reports or specific books was also used. Results: Findings were out lighted across the global status of HIV epidemic, HIV/AIDS epidemic in Sub-Saharan Africa, history of HIV and ART in South Africa, HIV infection and antiretroviral therapy, HIV life cycle, HIV treatment, Highly Active Antiretroviral Therapy, Adherence to HAART, and factors associated with HAART non-adherence. The reviewed literature revealed consistency in important factors associated with HAART non-adherence across multiple settings and countries. Conclusion: This review was to determine factors associated with non-adherence with highly active antiretroviral therapy among HIV-infected patients attending Lerato clinic in Gauteng, South Africa. The reviewed factors leading to non-adherence will be submitted to policymakers, health care workers in general, and Family medicine staff in particular.

Published in	International Journal of Infectious Diseases and Therapy (Volume 7, Issue 2)
DOI	10.11648/j.ijidt.20220702.11
Page(s)	25-28
Creative Commons	This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.
Copyright	Copyright © The Author(s), 2024. Published by Science Publishing Group

Keywords

Barriers to HAART, ARV, HIV Treatment, Antiretrovirals

References

[1]	WHO (2020). HIV/ AIDS surveillance in Europe-ECDC (online). Available from https://www.ecdc.europa.eu. (Accessed 17 January 2022).
[2]	HIV/AIDS (2021). Available at: https://www.who.int/News-room/fact-sheets/details/hiv-aids. (Accessed: 12 January 2022).
[3]	Global HIV and AIDS Statistics. Available from https://unaids.org/en/resources/fact-sheet. (Accessed 15 March 2022).
[4]	Global Fund to fight AIDS, Tuberculosis, and Malaria. Results report 2021. Available from. https://www.theglobalfund.org/en/results/. (Accessed 17 January 2022).
[5]	Nachega JB, Uthman OA, Peltzer K, Richardson LA, Mills EJ, Amekudzif K and Ouédraogof A. Association between antiretroviral therapy adherence and employment status: systematic review and meta-analysis. Bull World Health Organ 2015; 93: 29–41.
[6]	Crim SM, Tie Y, Beer L, Weiser J, Dasgupta S. Barriers to Antiretroviral Therapy Adherence Among HIV-Positive Hispanic and Latino Men Who Have Sex with Men —United States, 2015–2019. Morbidity and Mortality weekly report (MMWR). Weekly / October 9, 2020 / 69 (40); 1437–1442.
[7]	Rowell-Cunsolo TL and Hu G. Barriers to optimal antiretroviral therapy adherence among HIV-infected formerly incarcerated individuals in New York City. PLos ONE 15 (6): https://doi.org/10.1371/journal.pone.0233842. Published: June 1, 2020.
[8]	UNAIDS 2020. Global HIV and AIDS Statistics. Available from https://www.avert.org/global-hiv-and-aids-statistics. (Accessed 17 January 2022).
[9]	Ridgeway K, Dulli LS, Murray KR, Silverstein H, Dal Santo L, Olsen P, et al. (2018) Interventions to improve antiretroviral therapy adherence among adolescents in low- and middle-income countries: A systematic review of the literature. PLoS ONE 13 (1): e0189770. https://doi.org/10.1371/journal.pone.0189770. (Accessed 17 January 2022).
[10]	Mendelsohn, J. B., Schilperoord, M., Spiegel, P. et al. Adherence to antiretroviral therapy and treatment outcomes among conflict-affected and forcibly displaced populations: a systematic review. Confl Health 6, 9 (2012). https://doi.org/10.1186/1752-1505-6-9. (Accessed 17 January 2022).
[11]	Satoh S. and Bayer E. (2019). HIV in South Africa. Lancet, 394, pp. 467.
[12]	Simelela, N., et al., A Political and Social History of HIV in South Africa. Curr HIV/AIDS Rep, 2015. 12 (2): p. 256-61.
[13]	El-Khatib, Z., Ekstrom, A. M., Coovadia, A. et al. Adherence and virologic suppression during the first 24 weeks on antiretroviral therapy among women in Johannesburg, South Africa - a prospective cohort study. BMC Public Health 11, 88 (2011). https://doi.org/10.1186/1471-2458-11-88. (Accessed 17 January 2022).
[14]	National Institute of Health. HIV Overview. Available from: https://aidsinfo.nih.gov/education-materials/fact-sheets/19/46/the-stages-of-hiv-infection. (Accessed 17 January 2022).
[15]	Sutinen J. and Ristola M. (2012). HIV- tappavasta taudista krooniseksi sairaudeksi. Lääketieteellinen Aikakausikirja Duodecim, 128 (1), 37-42. Available from http://www.terveysporttti.fi. (Accessed 17 January 2022).
[16]	AIDSinfo. (2015). Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services. Available from http://www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf. (Accessed 17 January 2022).
[17]	Aidsmap (2021). HIV treatment, Zidovudine. Available from https://aidsmap.com/about-hiv/arv-background-information/zidovudine. (Accessed 17 January 2022).
[18]	Achappa B, Madi D, Bhaskaran U, Ramapuram JT, Rao S, Mahalingam S. Adherence to Antiretroviral Therapy Among People Living with HIV. N Am J Med Sci. 2013 Mar; 5 (3): 220-3. doi: 10.4103/1947-2714.109196. PMID: 23626959; PMCID: PMC3632027. (Accessed 17 January 2022)
[19]	Erlwanger AS, Joseph J, Gotora T, Muzunze B, Orne-Gliemann J, Mukungunugwa S, et al. Patterns of HIV Care Clinic Attendance and Adherence to Antiretroviral Therapy Among Pregnant and Breastfeeding Women Living with HIV in the Context of Option B+ in Zimbabwe. JAIDS Journal of Acquired Immune Deficiency Syndromes. 2017 Jun 1; 75: S 198.
[20]	Gary FA, Yarandi HA, Mathunjwa-Dlamini TR. Factors Influencing HIV-positive Expectant Mothers’ Adherence to ARV Prophylaxis (PMTCT) in a Healthcare Facility in the Hhohho Region, Swaziland. IJSAT. 2015; 5.
[21]	Weiser SD, Palar K, Frongillo EA, Tsai AC, Kumbakumba E, Depee S, et al. Longitudinal assessment of associations between food insecurity, antiretroviral adherence and HIV treatment outcomes in rural Uganda. AIDS. 2014; 28 (1): 115–20.
[22]	Ahmed CV, Jolly P, Padilla L, Malinga M, Harris C, Mthethwa N, et al. A qualitative analysis of the barriers to antiretroviral therapy initiation among children 2 to 18 months of age in Swaziland. African Journal of AIDS ReseDewing S, Mathews C, Fatti G, Grimwood A, Boulle A. Antiretroviral Adherence Interventions in Southern Africa: Implications for Using HIV Treatments for Prevention. Current HIV/AIDS Reports. 2014; 11 (1): 63–71. arch. 2017; 16 (4): 321–8.
[23]	Dewing S, Mathews C, Fatti G, Grimwood A, Boulle A. Antiretroviral Adherence Interventions in Southern Africa: Implications for Using HIV Treatments for Prevention. Current HIV/AIDS Reports. 2014; 11 (1): 63–71.

Cite This Article

Plain Text BibTeX RIS

APA Style

Nzale Nzali Ntumbanzondo Arnold, Nzale Nzali Kadiombo Tshilela Anastasie, Longo-Mbenza Benjamin, Nge Okwe Augustin, Kisoka Lusunsi Christian. (2022). Non-adherence to Highly Active Antiretroviral Treatment: Review. International Journal of Infectious Diseases and Therapy, 7(2), 25-28. https://doi.org/10.11648/j.ijidt.20220702.11

Copy | Download

ACS Style

Nzale Nzali Ntumbanzondo Arnold; Nzale Nzali Kadiombo Tshilela Anastasie; Longo-Mbenza Benjamin; Nge Okwe Augustin; Kisoka Lusunsi Christian. Non-adherence to Highly Active Antiretroviral Treatment: Review. Int. J. Infect. Dis. Ther. 2022, 7(2), 25-28. doi: 10.11648/j.ijidt.20220702.11

Copy | Download

AMA Style

Nzale Nzali Ntumbanzondo Arnold, Nzale Nzali Kadiombo Tshilela Anastasie, Longo-Mbenza Benjamin, Nge Okwe Augustin, Kisoka Lusunsi Christian. Non-adherence to Highly Active Antiretroviral Treatment: Review. Int J Infect Dis Ther. 2022;7(2):25-28. doi: 10.11648/j.ijidt.20220702.11

Copy | Download

@article{10.11648/j.ijidt.20220702.11,
  author = {Nzale Nzali Ntumbanzondo Arnold and Nzale Nzali Kadiombo Tshilela Anastasie and Longo-Mbenza Benjamin and Nge Okwe Augustin and Kisoka Lusunsi Christian},
  title = {Non-adherence to Highly Active Antiretroviral Treatment: Review},
  journal = {International Journal of Infectious Diseases and Therapy},
  volume = {7},
  number = {2},
  pages = {25-28},
  doi = {10.11648/j.ijidt.20220702.11},
  url = {https://doi.org/10.11648/j.ijidt.20220702.11},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ijidt.20220702.11},
  abstract = {Background and aims: This review aimed to describe factors associated with HAART non-adherence and did focus on the HIV/AIDS situation and antiretroviral therapy. Methods: The strategy of this review adopted a critical approach to reduce the bias of published or non-published information. Only evidence-based information was used from PubMed, Embase, Medline, and Google scholar. However, relevant grey information from monography/technical reports or specific books was also used. Results: Findings were out lighted across the global status of HIV epidemic, HIV/AIDS epidemic in Sub-Saharan Africa, history of HIV and ART in South Africa, HIV infection and antiretroviral therapy, HIV life cycle, HIV treatment, Highly Active Antiretroviral Therapy, Adherence to HAART, and factors associated with HAART non-adherence. The reviewed literature revealed consistency in important factors associated with HAART non-adherence across multiple settings and countries. Conclusion: This review was to determine factors associated with non-adherence with highly active antiretroviral therapy among HIV-infected patients attending Lerato clinic in Gauteng, South Africa. The reviewed factors leading to non-adherence will be submitted to policymakers, health care workers in general, and Family medicine staff in particular.},
 year = {2022}
}

Copy | Download

TY  - JOUR
T1  - Non-adherence to Highly Active Antiretroviral Treatment: Review
AU  - Nzale Nzali Ntumbanzondo Arnold
AU  - Nzale Nzali Kadiombo Tshilela Anastasie
AU  - Longo-Mbenza Benjamin
AU  - Nge Okwe Augustin
AU  - Kisoka Lusunsi Christian
Y1  - 2022/04/09
PY  - 2022
N1  - https://doi.org/10.11648/j.ijidt.20220702.11
DO  - 10.11648/j.ijidt.20220702.11
T2  - International Journal of Infectious Diseases and Therapy
JF  - International Journal of Infectious Diseases and Therapy
JO  - International Journal of Infectious Diseases and Therapy
SP  - 25
EP  - 28
PB  - Science Publishing Group
SN  - 2578-966X
UR  - https://doi.org/10.11648/j.ijidt.20220702.11
AB  - Background and aims: This review aimed to describe factors associated with HAART non-adherence and did focus on the HIV/AIDS situation and antiretroviral therapy. Methods: The strategy of this review adopted a critical approach to reduce the bias of published or non-published information. Only evidence-based information was used from PubMed, Embase, Medline, and Google scholar. However, relevant grey information from monography/technical reports or specific books was also used. Results: Findings were out lighted across the global status of HIV epidemic, HIV/AIDS epidemic in Sub-Saharan Africa, history of HIV and ART in South Africa, HIV infection and antiretroviral therapy, HIV life cycle, HIV treatment, Highly Active Antiretroviral Therapy, Adherence to HAART, and factors associated with HAART non-adherence. The reviewed literature revealed consistency in important factors associated with HAART non-adherence across multiple settings and countries. Conclusion: This review was to determine factors associated with non-adherence with highly active antiretroviral therapy among HIV-infected patients attending Lerato clinic in Gauteng, South Africa. The reviewed factors leading to non-adherence will be submitted to policymakers, health care workers in general, and Family medicine staff in particular.
VL  - 7
IS  - 2
ER  -

Copy | Download

Author Information

Nzale Nzali Ntumbanzondo Arnold

Department of Public Health, Lomo University of Research, Kinshasa, Democratic Republic of Congo
Nzale Nzali Kadiombo Tshilela Anastasie

Department of Internal Medicine, University of Kinshasa, Kinshasa, Democratic Republic of Congo
Longo-Mbenza Benjamin

Department of Public Health, Lomo University of Research, Kinshasa, Democratic Republic of Congo
Nge Okwe Augustin

Department of Public Health, Lomo University of Research, Kinshasa, Democratic Republic of Congo
Kisoka Lusunsi Christian

Department of Public Health, Lomo University of Research, Kinshasa, Democratic Republic of Congo

Download PDF

Sections

Plain Text BibTeX RIS

APA Style

Nzale Nzali Ntumbanzondo Arnold, Nzale Nzali Kadiombo Tshilela Anastasie, Longo-Mbenza Benjamin, Nge Okwe Augustin, Kisoka Lusunsi Christian. (2022). Non-adherence to Highly Active Antiretroviral Treatment: Review. International Journal of Infectious Diseases and Therapy, 7(2), 25-28. https://doi.org/10.11648/j.ijidt.20220702.11

Copy | Download

ACS Style

Nzale Nzali Ntumbanzondo Arnold; Nzale Nzali Kadiombo Tshilela Anastasie; Longo-Mbenza Benjamin; Nge Okwe Augustin; Kisoka Lusunsi Christian. Non-adherence to Highly Active Antiretroviral Treatment: Review. Int. J. Infect. Dis. Ther. 2022, 7(2), 25-28. doi: 10.11648/j.ijidt.20220702.11

Copy | Download

AMA Style

Nzale Nzali Ntumbanzondo Arnold, Nzale Nzali Kadiombo Tshilela Anastasie, Longo-Mbenza Benjamin, Nge Okwe Augustin, Kisoka Lusunsi Christian. Non-adherence to Highly Active Antiretroviral Treatment: Review. Int J Infect Dis Ther. 2022;7(2):25-28. doi: 10.11648/j.ijidt.20220702.11

Copy | Download

@article{10.11648/j.ijidt.20220702.11,
  author = {Nzale Nzali Ntumbanzondo Arnold and Nzale Nzali Kadiombo Tshilela Anastasie and Longo-Mbenza Benjamin and Nge Okwe Augustin and Kisoka Lusunsi Christian},
  title = {Non-adherence to Highly Active Antiretroviral Treatment: Review},
  journal = {International Journal of Infectious Diseases and Therapy},
  volume = {7},
  number = {2},
  pages = {25-28},
  doi = {10.11648/j.ijidt.20220702.11},
  url = {https://doi.org/10.11648/j.ijidt.20220702.11},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ijidt.20220702.11},
  abstract = {Background and aims: This review aimed to describe factors associated with HAART non-adherence and did focus on the HIV/AIDS situation and antiretroviral therapy. Methods: The strategy of this review adopted a critical approach to reduce the bias of published or non-published information. Only evidence-based information was used from PubMed, Embase, Medline, and Google scholar. However, relevant grey information from monography/technical reports or specific books was also used. Results: Findings were out lighted across the global status of HIV epidemic, HIV/AIDS epidemic in Sub-Saharan Africa, history of HIV and ART in South Africa, HIV infection and antiretroviral therapy, HIV life cycle, HIV treatment, Highly Active Antiretroviral Therapy, Adherence to HAART, and factors associated with HAART non-adherence. The reviewed literature revealed consistency in important factors associated with HAART non-adherence across multiple settings and countries. Conclusion: This review was to determine factors associated with non-adherence with highly active antiretroviral therapy among HIV-infected patients attending Lerato clinic in Gauteng, South Africa. The reviewed factors leading to non-adherence will be submitted to policymakers, health care workers in general, and Family medicine staff in particular.},
 year = {2022}
}

Copy | Download

TY  - JOUR
T1  - Non-adherence to Highly Active Antiretroviral Treatment: Review
AU  - Nzale Nzali Ntumbanzondo Arnold
AU  - Nzale Nzali Kadiombo Tshilela Anastasie
AU  - Longo-Mbenza Benjamin
AU  - Nge Okwe Augustin
AU  - Kisoka Lusunsi Christian
Y1  - 2022/04/09
PY  - 2022
N1  - https://doi.org/10.11648/j.ijidt.20220702.11
DO  - 10.11648/j.ijidt.20220702.11
T2  - International Journal of Infectious Diseases and Therapy
JF  - International Journal of Infectious Diseases and Therapy
JO  - International Journal of Infectious Diseases and Therapy
SP  - 25
EP  - 28
PB  - Science Publishing Group
SN  - 2578-966X
UR  - https://doi.org/10.11648/j.ijidt.20220702.11
AB  - Background and aims: This review aimed to describe factors associated with HAART non-adherence and did focus on the HIV/AIDS situation and antiretroviral therapy. Methods: The strategy of this review adopted a critical approach to reduce the bias of published or non-published information. Only evidence-based information was used from PubMed, Embase, Medline, and Google scholar. However, relevant grey information from monography/technical reports or specific books was also used. Results: Findings were out lighted across the global status of HIV epidemic, HIV/AIDS epidemic in Sub-Saharan Africa, history of HIV and ART in South Africa, HIV infection and antiretroviral therapy, HIV life cycle, HIV treatment, Highly Active Antiretroviral Therapy, Adherence to HAART, and factors associated with HAART non-adherence. The reviewed literature revealed consistency in important factors associated with HAART non-adherence across multiple settings and countries. Conclusion: This review was to determine factors associated with non-adherence with highly active antiretroviral therapy among HIV-infected patients attending Lerato clinic in Gauteng, South Africa. The reviewed factors leading to non-adherence will be submitted to policymakers, health care workers in general, and Family medicine staff in particular.
VL  - 7
IS  - 2
ER  -

Copy | Download